What is the appropriate workup for a 74-year-old male with a history of Benign Prostatic Hyperplasia (BPH) and prostate cancer presenting with new onset hematuria?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Workup for a 74-Year-Old Male with BPH and Prostate Cancer Presenting with New Onset Hematuria

A comprehensive hematuria workup is mandatory for this patient, including cystoscopy, upper tract imaging, and urine cytology, as hematuria in a 74-year-old male with history of BPH and prostate cancer represents a high-risk scenario for urological malignancy.

Initial Assessment

The presentation of new onset hematuria in this patient requires urgent evaluation due to several high-risk factors:

  • Advanced age (74 years)
  • Male gender
  • History of prostate cancer
  • History of BPH

Laboratory Testing

  1. Urinalysis and urine culture

    • To confirm hematuria and rule out infection 1
    • Assess for pyuria, bacteriuria, and other abnormalities
  2. Urine cytology

    • Essential in this high-risk patient with history of malignancy
    • Helps detect urothelial carcinoma 1
  3. PSA testing

    • Important to assess for prostate cancer progression
    • Useful in monitoring disease status in a patient with known prostate cancer 1
  4. Complete blood count

    • To assess degree of blood loss and baseline hemoglobin
  5. Renal function tests

    • Serum creatinine to assess kidney function 1

Imaging Studies

  1. CT Urography

    • Preferred imaging modality for upper tract evaluation 1
    • Provides comprehensive assessment of kidneys, ureters, and bladder
    • Should be performed before any invasive procedures if solid/sessile tumor is suspected 1
  2. If CT is contraindicated:

    • MRI urogram
    • Renal ultrasound with retrograde pyelogram 1

Endoscopic Evaluation

  1. Cystoscopy

    • Mandatory to directly visualize the bladder and urethra 1
    • Should be performed by a urologist
    • Allows for assessment of:
      • Bladder tumors
      • Prostatic urethra
      • Bleeding sources in the prostate
  2. Transurethral resection of suspicious lesions

    • If abnormalities are identified during cystoscopy
    • Provides tissue for histopathological examination 1

Special Considerations for This Patient

BPH-Related Hematuria

  • BPH can cause hematuria due to increased vascularity of the prostate 2, 3
  • However, in a patient with history of prostate cancer, this should be considered a diagnosis of exclusion

Prostate Cancer-Related Hematuria

  • Prostate cancer itself can cause hematuria, especially in advanced disease 4
  • Patients with prostate cancer who develop hematuria have a worse prognosis (median survival of 13 months after hematuria onset) 4

Bladder Cancer Risk

  • Patients with hematuria and prostate cancer have a higher risk of bladder cancer
  • In patients who underwent radical prostatectomy, bladder cancer was found to be the cause of hematuria in 38.5% of cases 4

Management Algorithm

  1. Immediate management:

    • Assess hemodynamic stability
    • Consider bladder irrigation if clots are present
    • Treat any identified UTI
  2. Diagnostic workup:

    • Complete laboratory testing (urinalysis, cytology, PSA, CBC, renal function)
    • CT urography
    • Cystoscopy by urologist
  3. If bleeding source identified:

    • Directed treatment based on etiology
    • For BPH-related bleeding: consider 5-alpha reductase inhibitors (finasteride/dutasteride) 3, 5
    • For tumor-related bleeding: appropriate oncological management
  4. If initial workup negative:

    • Consider prostatic urethral biopsies
    • Enhanced cystoscopic techniques (blue light cystoscopy if available) 1
    • Random bladder biopsies if indicated

Pitfalls to Avoid

  1. Do not attribute hematuria solely to BPH without complete evaluation

    • Even with known BPH, malignant causes must be excluded 3
  2. Do not delay evaluation

    • Gross hematuria has up to 30-40% association with malignancy 1
  3. Do not stop at finding one potential cause

    • Multiple pathologies can coexist, especially in this high-risk patient
  4. Do not forget to evaluate the upper urinary tract

    • Complete evaluation includes both lower and upper urinary tract assessment 1
  5. Do not assume prostate cancer is the cause without ruling out bladder cancer

    • Bladder cancer is a common cause of hematuria in patients with history of prostate cancer 4

This patient requires urgent and thorough evaluation by a urologist with expertise in oncology, given his high-risk profile and concerning presentation.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.